International Experience in Therapeutic Value and Value-Based Pricing: A Rapid Review of the Literature
- 1 December 2020
- journal article
- review article
- Published by Elsevier in Value in Health Regional Issues
- Vol. 23, 37-48
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Inequidades en salud entre países de Latinoamérica y el Caribe (2005-2010)Gaceta Sanitaria, 2013
- Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislationThe European Journal of Health Economics, 2013
- New drug regulations in France: what are the impacts on market access? Part 1 – Overview of new drug regulations in FranceJournal of Market Access & Health Policy, 2013
- Operationalizing Value-Based Pricing of MedicinesPharmacoEconomics, 2012
- Value-Based PricingPharmaceutical Medicine, 2012
- A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market PricingApplied Health Economics and Health Policy, 2012
- The conceptualization of value-based pricing in industrial firmsJournal of Revenue and Pricing Management, 2011
- Reducing Uncertainty in Value-Based Pricing Using Evidence Development AgreementsApplied Health Economics and Health Policy, 2010
- Value based pricing, research and development, and patient access schemes. Will the United Kingdom get it right or wrong?British Journal of Clinical Pharmacology, 2010
- Value based pricing for NHS medicines: magic bullet, counterfeit treatment or the mixture as before?Health Economics, Policy and Law, 2009